Eli Lilly and Company
1 official
2026-09-21
Intent: To provide stakeholders with an understanding on emerging trends in scientific/clinical research.
Details: Emerging trends in scientific research.
Officials
Methods
Email
Official Profile
Most Recent Title
Assistant Secretary
Most Recent Public Body
Department of Health
First Seen
13 January 2016
Last Seen
21 September 2026
Observed Titles
Assistant Secretary
Observed Public Bodies
Department of Health
Current Oireachtas Committee Memberships
No current committee memberships matched for this official.
All Lobbyists
Select methods...
Lobbying Records (Page 1 of 18)
Takeda Products Ireland
12 officials
2026-09-21
Intent: To contribute to discussions, in the context of Ireland’s EU Presidency, on the EU Biotech Act and related health-policy initiatives and their potential contribution to life-sciences innovation, research, clinical trials and healthcare outcomes in Ireland and Europe.
Details: Engagements on life-sciences policy, innovation and competitiveness in Ireland and Europe
Officials
Methods
Attended and spoke at the EU Presidency Forum on 2nd of July 2026 - Event / ReceptionInformal discussions with MEPs and members of the European Committee of Regions at the EU Presidency Forum on July 2nd 2026 - Informal communicationParticipation in the Life Sciences Leadership event in the RCSI on June 18th 2026. - Event / Reception
Rare Diseases Ireland
21 officials
2026-09-21
Intent: Attendance at upcoming Associated EU Presidency on Rare Diseases on Nov 13
Details: Invitation to attend RDI's associated EU Presidency Event
Officials
Methods
Email to some TDs, Senators & HSE leadership asking them to Save the Date for the RDI Associated EU Presidency Event on Nov 13 - Email
Irish Pharmaceutical Healthcare Association
1 official
2026-09-21
Current/Former DPOFAQ
Intent: Providing an overview from the innovative pharmaceutical industry association in the BeNeLuxa countries as a basis for further engagement in constructive dialogue on access and affordability of medicines in Europe.
Details: Industry perspectives on access, innovation and coordination.
Officials
Methods
Email
Novartis Ireland Limited
26 officials
2026-09-18
Intent: System shaping for advanced therapies like radioligand therapy and accelerating the time to access for patients in Ireland. ::Policy actions to reduce delays in patient access to innovative medicines
Details: Valuing Innovation & Advanced Cancer Therapy - policy and access
Officials
Methods
All Island Cancer Summit on the 19th May in Croke Park, HPP white paper on advanced therapies launched. Shared the report with DPOs after the event. - Event / ReceptionAttended evening in Leinster House with Dublin Chamber of Commerce and discussed the importance of valuing innovation in government policy with some attendees. - Event / ReceptionBrief conversations at the US Ambassadors Independence Day evening, July 2026. - Informal communication
Novartis Ireland Limited
4 officials
2026-09-18
Intent: To encourage Government action to improve timely patient access to innovative medicines, ensure health system readiness for advanced therapies including radioligand therapy, and support the development and implementation of Ireland's National Life Sciences Strategy.
Details: Life Science Strategy
Methods
Attended and spoke at the joint Ministerial Life Sciences Leadership event, Royal College of Physicians, 18th June 2026.Briefly talked to Minister for Health about improved patient access to innovation. - Event / Reception
Ibec
6 officials
2026-09-18
Intent: Ensure sustained growth of Ireland's Life Sciences ecosystem via National Strategy.
Details: Inter-Ministerial Meeting convened in Royal College of Physicians
Methods
Event / ReceptionSocial Media
Ibec
20 officials
2026-09-18
Intent: Secure targeted government funding and supports for the MedTech sector.
Details: Irish Medtech Budget 2027 submission
Officials
Methods
EmailSocial MediaSubmission
Ibec
2 officials
2026-09-18
Intent: Ensure effective, industry-aligned implementation of EHDS.
Details: European Health Data Space (EHDS)
Officials
Methods
EmailEvent / ReceptionSocial Media
Pfizer
15 officials
2026-09-18
Intent: Highlight the importance of the roll-out of an RSV National Immunisation Programme for older adults::To ensure that the burden of RSV disease among older adults, including acknowledged limitations in testing, surveillance and disease burden estimation, is appropriately considered in policy decision-making regarding the potential implementation of RSV vaccination through the National Immunisation Programme in Ireland.::To highlight the importance of prevention and adult vaccination in improving health outcomes for patients, healthcare systems, and society
Details: Expansion of the National Immunisation Programme to include RSV vaccination for older adults
Officials
Methods
Provide information materials for briefing event relating to RSV disease burden, healthy ageing and international approaches to immunisation. - MeetingEmailLetter
…